JPS60120811A - 軟質ゼラチンカプセル - Google Patents
軟質ゼラチンカプセルInfo
- Publication number
- JPS60120811A JPS60120811A JP22858083A JP22858083A JPS60120811A JP S60120811 A JPS60120811 A JP S60120811A JP 22858083 A JP22858083 A JP 22858083A JP 22858083 A JP22858083 A JP 22858083A JP S60120811 A JPS60120811 A JP S60120811A
- Authority
- JP
- Japan
- Prior art keywords
- gelatin
- capsule
- acting substance
- soft gelatin
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000007903 gelatin capsule Substances 0.000 title claims abstract description 15
- 239000003814 drug Substances 0.000 claims abstract description 14
- 108010010803 Gelatin Proteins 0.000 claims abstract description 13
- 239000008273 gelatin Substances 0.000 claims abstract description 13
- 229920000159 gelatin Polymers 0.000 claims abstract description 13
- 235000019322 gelatine Nutrition 0.000 claims abstract description 13
- 235000011852 gelatine desserts Nutrition 0.000 claims abstract description 13
- 210000000214 mouth Anatomy 0.000 claims abstract description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 7
- 210000004400 mucous membrane Anatomy 0.000 claims abstract description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 3
- 239000013543 active substance Substances 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 2
- 229940079593 drug Drugs 0.000 abstract description 12
- 239000000126 substance Substances 0.000 abstract description 9
- 239000002775 capsule Substances 0.000 abstract description 7
- 208000002925 dental caries Diseases 0.000 abstract description 2
- 230000007794 irritation Effects 0.000 abstract description 2
- 239000007788 liquid Substances 0.000 abstract description 2
- 239000007787 solid Substances 0.000 abstract description 2
- 229940098465 tincture Drugs 0.000 abstract description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- 239000002671 adjuvant Substances 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 210000003800 pharynx Anatomy 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 230000000246 remedial effect Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 description 7
- 238000011282 treatment Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 210000002200 mouth mucosa Anatomy 0.000 description 2
- 239000012487 rinsing solution Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22858083A JPS60120811A (ja) | 1983-12-05 | 1983-12-05 | 軟質ゼラチンカプセル |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP22858083A JPS60120811A (ja) | 1983-12-05 | 1983-12-05 | 軟質ゼラチンカプセル |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60120811A true JPS60120811A (ja) | 1985-06-28 |
| JPH0466205B2 JPH0466205B2 (en, 2012) | 1992-10-22 |
Family
ID=16878586
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP22858083A Granted JPS60120811A (ja) | 1983-12-05 | 1983-12-05 | 軟質ゼラチンカプセル |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60120811A (en, 2012) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004056337A3 (en) * | 2002-12-18 | 2004-08-19 | Pain Therapeutics | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| US8133507B2 (en) | 2002-12-13 | 2012-03-13 | Durect Corporation | Oral drug delivery system |
| US9616055B2 (en) | 2008-11-03 | 2017-04-11 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9655861B2 (en) | 2007-12-06 | 2017-05-23 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9855333B2 (en) | 2013-03-15 | 2018-01-02 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US12274794B2 (en) | 2016-07-06 | 2025-04-15 | Orient Pharma Co., Ltd. | Oral dosage form with drug composition, barrier layer and drug layer |
-
1983
- 1983-12-05 JP JP22858083A patent/JPS60120811A/ja active Granted
Cited By (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9918982B2 (en) | 2002-12-13 | 2018-03-20 | Durect Corporation | Oral drug delivery system |
| US8133507B2 (en) | 2002-12-13 | 2012-03-13 | Durect Corporation | Oral drug delivery system |
| US8147870B2 (en) | 2002-12-13 | 2012-04-03 | Durect Corporation | Oral drug delivery system |
| US8153152B2 (en) | 2002-12-13 | 2012-04-10 | Durect Corporation | Oral drug delivery system |
| US8168217B2 (en) | 2002-12-13 | 2012-05-01 | Durect Corporation | Oral drug delivery system |
| US8354124B2 (en) | 2002-12-13 | 2013-01-15 | Durect Corporation | Oral drug delivery system |
| WO2004056337A3 (en) * | 2002-12-18 | 2004-08-19 | Pain Therapeutics | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| US10206883B2 (en) | 2007-12-06 | 2019-02-19 | Durect Corporation | Oral pharamaceutical dosage forms |
| US9655861B2 (en) | 2007-12-06 | 2017-05-23 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9884056B2 (en) | 2008-11-03 | 2018-02-06 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9616055B2 (en) | 2008-11-03 | 2017-04-11 | Durect Corporation | Oral pharmaceutical dosage forms |
| US10328068B2 (en) | 2008-11-03 | 2019-06-25 | Durect Corporation | Oral pharmaceutical dosage forms |
| US9855333B2 (en) | 2013-03-15 | 2018-01-02 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US9907851B2 (en) | 2013-03-15 | 2018-03-06 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US10300142B2 (en) | 2013-03-15 | 2019-05-28 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
| US12274794B2 (en) | 2016-07-06 | 2025-04-15 | Orient Pharma Co., Ltd. | Oral dosage form with drug composition, barrier layer and drug layer |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0466205B2 (en, 2012) | 1992-10-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU707749B2 (en) | Medical Treatment | |
| MXPA02003312A (es) | Composiciones que tienen estabilidad mejorada. | |
| EP3481428B1 (en) | Orally dissolving mucoadhesive films in managing oral care | |
| HUE030921T2 (en) | Pharmaceutical preparations containing a local anesthetic such as bupivacaine for topical administration to the mouth or throat | |
| JP2006525986A (ja) | 喉に医薬活性剤をデリバリーするための菓子製品 | |
| JPH059412B2 (en, 2012) | ||
| BRPI0620403B1 (pt) | filme bioadesivo, unidade de dosagem, método de fabricação de um filme bioadesivo, e, uso de uma composição | |
| JP5897509B2 (ja) | 口内で使用される窪みのある接着性口内パッチ | |
| CA2905991C (en) | Compositions for treatment of xerostomia and for tooth treatment | |
| SE502746C2 (sv) | Komposition för långsam avgivning av flour- och kalciumjon | |
| JPH0729916B2 (ja) | 鎮痛性を有する医薬組成物 | |
| JPS61275220A (ja) | 新規薬学的組成物 | |
| JPS60120811A (ja) | 軟質ゼラチンカプセル | |
| AU607154B2 (en) | Oral sustained release preparation of sodium monofluorophosphate | |
| US20130216594A1 (en) | Preparation of orodispersible films | |
| JPH08295637A (ja) | 口腔部局所投与剤 | |
| JP2009505693A (ja) | 局所投与のための薬剤送達システム | |
| EA006582B1 (ru) | Фармацевтический дезинфицирующий препарат на основе уснината натрия и лекарственных растений, (его варианты) и способы их изготовления | |
| RU2362541C2 (ru) | Самоклеющаяся зубная пленка | |
| US2333950A (en) | Therapeutic pectous product | |
| JPH10203963A (ja) | 殺菌性物質と粘膜付着性物質を含む口内投与用医薬品組成物 | |
| JP2006347958A (ja) | 咽頭粘膜抗炎症スプレー剤 | |
| RU2201194C2 (ru) | Лекарственная пленка для лечения воспалительных заболеваний пародонта "пиявит" | |
| RU2197950C2 (ru) | Средство для полоскания полости рта | |
| RU2216320C1 (ru) | Средство фарингал для профилактики и лечения инфекционно-воспалительных заболеваний ротоглотки |